Methodological considerations, such as directed acyclic graphs, for studying "acute on chronic" disease epidemiology: Chronic obstructive pulmonary disease example

被引:22
作者
Tsai, Chu-Lin [1 ,2 ]
Camargo, Carlos A., Jr. [2 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Emergency Med,EMNet Coordinating Ctr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02114 USA
关键词
Acute exacerbation; Casual inference; Chronic obstructive pulmonary disease; Epidemiological methods; Number needed to treat; Statistics; BODY-MASS INDEX; MARGINAL STRUCTURAL MODELS; QUALITY-OF-LIFE; EMERGENCY-DEPARTMENT VISITS; CASE-CROSSOVER; HEALTH-STATUS; STATISTICAL TREATMENT; CLINICAL-USEFULNESS; COPD EXACERBATIONS; RECURRENT EVENTS;
D O I
10.1016/j.jclinepi.2008.10.005
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Acute exacerbations of chronic disease are ubiquitous in clinical medicine, and thus far, there has been a paucity of integrated methodological discussion on this phenomenon. Study Design and Setting: We use acute exacerbations of chronic obstructive pulmonary disease as an example to emphasize key epidemiological and statistical issues for this understudied field in clinical epidemiology. Results: Directed acyclic graphs are a useful epidemiological tool to explain the differential effects of risk factor on health outcomes in studies of acute and chronic phases of disease. To study the pathogenesis of acute exacerbations of chronic disease, case-crossover design and time-series analysis are well-suited study designs to differentiate acute and chronic effect. Modeling changes over time and setting appropriate thresholds are important steps to separate acute from chronic phases of disease in serial measurements. In statistical analysis, acute exacerbations are recurrent events, and some individuals are more prone to recurrences than others. Therefore, appropriate statistical modeling should take into account intraindividual dependence. Finally, we recommend the use of "event-based" number needed to treat (NNT) to prevent a single exacerbation instead of traditional patient-based NNT. Conclusion: Addressing these methodological challenges will advance research quality in acute on chronic disease epidemiology. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:982 / 990
页数:9
相关论文
共 74 条
[1]   Counting, analysing and reporting exacerbations of COPD in randomised controlled trials [J].
Aaron, S. D. ;
Fergusson, D. ;
Marks, G. B. ;
Suissa, S. ;
Vandemheen, K. L. ;
Doucette, S. ;
Maltais, F. ;
Bourbeau, J. F. ;
Goldstein, R. S. ;
Balter, M. ;
O'Donnell, D. ;
FitzGerald, M. .
THORAX, 2008, 63 (02) :122-128
[2]  
Aaron SD, 2007, AM J RESP CRIT CARE, V175, P1347
[3]   Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: Results from the APHEA project [J].
Anderson, HR ;
Spix, C ;
Medina, S ;
Schouten, JP ;
Castellsague, J ;
Rossi, G ;
Zmirou, D ;
Touloumi, G ;
Wojtyniak, B ;
Ponka, A ;
Bacharova, L ;
Schwartz, J ;
Katsouyanni, K .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (05) :1064-1071
[4]  
Bland JM, 1996, BRIT MED J, V313, P744
[5]   Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Anderson, Julie A. ;
Celli, Bartolome ;
Ferguson, Gary T. ;
Jenkins, Christine ;
Jones, Paul W. ;
Yates, Julie C. ;
Vestbo, Jorgen ;
Calverley, P. M. A. ;
Anderson, J. A. ;
Celli, B. ;
Ferguson, G. T. ;
Jenkins, C. ;
Jones, P. W. ;
Knobil, K. ;
Yates, J. C. ;
Vestbo, J. ;
Cherniack, R. ;
Similowski, T. ;
Cleland, J. ;
Whitehead, A. ;
Wise, R. ;
McGarvey, L. ;
John, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :775-789
[6]   Prospective study of body mass index, weight change, and risk of adult-onset asthma in women [J].
Camargo, CA ;
Weiss, ST ;
Zhang, SM ;
Willett, WC ;
Speizer, FE .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (21) :2582-2588
[7]   Outcomes for COPD pharmacological trials:: from lung function to biomarkers [J].
Cazzola, M. ;
MacNee, W. ;
Martinez, F. J. ;
Rabe, K. F. ;
Franciosi, L. G. ;
Barnes, P. J. ;
Brusasco, V. ;
Burge, P. S. ;
Calverley, P. M. A. ;
Celli, B. R. ;
Jones, P. W. ;
Mahler, D. A. ;
Make, B. ;
Miravitlles, M. ;
Page, C. P. ;
Palange, P. ;
Parr, D. ;
Pistolesi, M. ;
Rennard, S. I. ;
Moelken, M. P. Rutten-Van ;
Stockley, R. ;
Sullivan, S. D. ;
Wedzicha, J. A. ;
Wouters, E. F. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (02) :416-468
[8]   The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J].
Celli, BR ;
Cote, CG ;
Marin, JM ;
Casanova, C ;
de Oca, MM ;
Mendez, RA ;
Pinto Plata, V ;
Cabral, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :1005-1012
[9]   Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study [J].
Choi, HK ;
Hernán, MA ;
Seeger, JD ;
Robins, JM ;
Wolfe, F .
LANCET, 2002, 359 (9313) :1173-1177
[10]   Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count [J].
Cole, SR ;
Hernán, MA ;
Margolick, JB ;
Cohen, MH ;
Robins, JM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 162 (05) :471-478